Big pharma teams up with Indian generic drug maker
Updated
A deal between the global pharmaceutical company GlaxoSmithKline and an Indian manufacturer of cheap generic drugs could potentially mark a new era in the global medicine business. Generic drugs are cheaper versions of medicines which are otherwise sold at higher prices by leading pharmaceutical companies. And the big companies have often been accused of trying to stop generic drugs from cutting into their profits. But one of the biggest medicine companies in the world has now teamed up with a large generic drug manufacturer in India.
Presenter: Matt Abud
Speakers: Satish Reddy, chief operating officer, Dr. Reddy's Laboratories; Sangeeta Shashikant, legal advisor, Third World Network
- Listen:
- Windows Media












